Owlet Inc gets FDA approval for its BabySat product, which is a medical-grade pulse-ox monitor that is designed in the form of a wireless sock for newborns and babies. Kurt Workman, the CEO and Co-Founder of Owlet shares the journey of getting FDA approval, stating that "our technology is medical-grade. We conducted several side-by-side accuracy comparisons to hospital monitors and that demonstrated Owlet is accurate."
The BabySat device is able to alert a provider if there are any metrics that are out of range and of concern. With this data, providers can help find diagnoses and prevent complications. It added an average oxygen level through a software update and the wearable is priced at $299.
Medical Baby-Monitoring Socks
Owlet Inc Gets FDA Approval for its BabySat Sock Technology
Trend Themes
1. Wearable Medical Devices - Disruptive innovation opportunity: Develop new wearable medical devices that leverage technology to monitor and alert for potential health issues in infants.
2. Wireless Monitoring Technology - Disruptive innovation opportunity: Explore the use of wireless monitoring technology in various industries to enhance data collection, analysis, and monitoring capabilities.
3. Accuracy in Medical Monitoring - Disruptive innovation opportunity: Develop advanced technology with high accuracy in medical monitoring to improve diagnostic capabilities and prevent complications.
Industry Implications
1. Healthcare - Disruptive innovation opportunity: Implement wearable medical devices and wireless monitoring technology to revolutionize patient care and diagnostics.
2. Consumer Electronics - Disruptive innovation opportunity: Integrate wireless monitoring technology into consumer electronics, providing users with real-time health monitoring and management capabilities.
3. Infant Care - Disruptive innovation opportunity: Develop innovative solutions for monitoring and improving infant health and safety, offering peace of mind to parents and caregivers.